XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt
9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Debt

9. Debt

Our debt consisted of the following (in millions):

 

 

 

September 30,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Current portion of long-term debt

 

 

 

 

 

 

3.150% Senior Notes due 2022

 

$

-

 

 

$

750.0

 

Japan Term Loan A due 2022

 

 

-

 

 

 

101.6

 

Japan Term Loan B due 2022

 

 

-

 

 

 

184.9

 

1.414% Euro Notes due 2022

 

 

489.8

 

 

 

568.6

 

Short-Term Term Loan

 

 

83.0

 

 

 

-

 

3.700% Senior Notes due 2023

 

 

86.3

 

 

 

-

 

Total current portion of long-term debt

 

$

659.1

 

 

$

1,605.1

 

Long-term debt

 

 

 

 

 

 

3.700% Senior Notes due 2023

 

 

-

 

 

 

86.3

 

1.450% Senior Notes due 2024

 

 

850.0

 

 

 

850.0

 

3.550% Senior Notes due 2025

 

 

863.0

 

 

 

863.0

 

3.050% Senior Notes due 2026

 

 

600.0

 

 

 

600.0

 

3.550% Senior Notes due 2030

 

 

257.5

 

 

 

257.5

 

2.600% Senior Notes due 2031

 

 

750.0

 

 

 

750.0

 

4.250% Senior Notes due 2035

 

 

253.4

 

 

 

253.4

 

5.750% Senior Notes due 2039

 

 

317.8

 

 

 

317.8

 

4.450% Senior Notes due 2045

 

 

395.4

 

 

 

395.4

 

2.425% Euro Notes due 2026

 

 

489.8

 

 

 

568.6

 

1.164% Euro Notes due 2027

 

 

489.8

 

 

 

568.6

 

Debt discount and issuance costs

 

 

(31.7

)

 

 

(36.4

)

Adjustment related to interest rate swaps

 

 

(179.8

)

 

 

(10.5

)

Total long-term debt

 

$

5,055.2

 

 

$

5,463.7

 

 

At September 30, 2022, our total current and non-current debt of $5.7 billion consisted of $5.8 billion aggregate principal amount of our senior notes, which included €1.5 billion Euro-denominated senior notes (“Euro Notes”), and an $83.0 million borrowing under a short-term credit agreement (the "Short-Term Term Loan"), partially offset by debt discount and issuance costs of $31.7 million and fair value adjustments related to interest rate swaps totaling $179.8 million.

 

On September 22, 2022, we used cash on hand to redeem the full ¥11.7 billion and ¥21.3 billion outstanding principal amounts of our Japanese Term Loan A and Japanese Term Loan B, respectively.

 

On August 31, 2022, we borrowed an aggregate principal amount of $83.0 million under the Short-Term Term Loan with a third-party financial institution, the proceeds of which will be used to redeem a portion of the 1.414% Euro Notes that mature on December 13, 2022. As more fully described in Note 2, the Short-Term Term Loan is expected to be settled in the first quarter of 2023.

 

On March 18, 2022, we redeemed the full $750.0 million outstanding principal amount of our 3.150% Senior Notes due April 1, 2022. A $100.0 million draw under the 2021 Five-Year Revolving Facility (as defined below), together with cash on hand, were used to redeem these notes. $540.6 million of this cash on hand came from the dividend paid by ZimVie to Zimmer Biomet at separation. In total, in the nine-month period ended September 30, 2022 we borrowed and subsequently repaid $220.0 million under the 2021 Five-Year Revolving Facility to pay off debt, complete an acquisition and for other obligations.

 

In the nine-month period ended September 30, 2021, we redeemed $200.0 million outstanding principal amount of our floating rate notes due 2021 and $300.0 million on senior notes due 2021.

 

On August 19, 2022, we entered into a new five-year revolving credit agreement (the “2022 Five-Year Credit Agreement”) and a new 364-day revolving credit agreement (the “2022 364-Day Revolving Credit Agreement”), as described below. Borrowings under these credit agreements will be used for general corporate purposes.

 

The 2022 Five-Year Credit Agreement contains a five-year unsecured revolving facility of $1.5 billion (the “2022 Five-Year Revolving Facility”). The 2022 Five-Year Credit Agreement replaces the previous revolving credit agreement (the “2021 Five-Year Credit Agreement”), which contained a five-year unsecured multicurrency revolving facility of $1.5 billion (the “2021 Five-Year Revolving Facility”). There were no borrowings outstanding under the 2021 Five-Year Credit Agreement at the time it was terminated.

 

The 2022 Five-Year Credit Agreement will mature on August 19, 2027, with two one-year extensions exercisable at our discretion and subject to required lender consent. The 2022 Five-Year Credit Agreement also includes an uncommitted incremental feature allowing us to request an increase of the facility by an aggregate amount of up to $500.0 million.

 

Borrowings under the 2022 Five-Year Credit Agreement bear interest at floating rates, based upon either an adjusted Term secured overnight financing rate (“SOFR”) for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2022 Five-Year Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2022 Five-Year Credit Agreement contains customary affirmative and negative covenants and events of default for unsecured financing arrangements, including, among other things, limitations on consolidations, mergers, and sales of assets. The 2022 Five-Year Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 for a period of time in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2022 Five-Year Credit Agreement as of September 30, 2022. As of September 30, 2022, there were no outstanding borrowings under the 2022 Five-Year Credit Agreement.

 

The 2022 364-Day Revolving Credit Agreement is an unsecured revolving credit facility in the principal amount of $1.0 billion (the “2022 364-Day Revolving Facility”). The 2022 364-Day Revolving Credit Agreement replaced a credit agreement entered into on August 20, 2021, which was also a 364- day unsecured revolving credit facility of $1.0 billion (the “2021 364-Day Revolving Facility”). There were no borrowings outstanding under the 2021 364-Day Revolving Facility when it was terminated.

 

The 2022 364-Day Revolving Facility will mature on August 18, 2023. Borrowings under the 2022 364-Day Revolving Credit Agreement bear interest at floating rates based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to our senior unsecured long-term debt credit rating. We pay a facility fee on the aggregate amount of the 2022 364-Day Revolving Facility at a rate determined by reference to our senior unsecured long-term debt credit rating. The 2022 364-Day Revolving Credit Agreement contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement including, among other things, limitations on consolidations, mergers, and sales of assets. The 2022 364-Day Revolving Credit Agreement also requires us to maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 in connection with a qualified material acquisition and certain other restrictions). We were in compliance with all covenants under the 2022 364-Day Revolving Credit Agreement as of September 30, 2022. As of September 30, 2022, there were no outstanding borrowings under the 2022 364-Day Revolving Credit Agreement.

 

The estimated fair value of our senior notes, which includes our Euro notes, as of September 30, 2022, based on quoted prices for the specific securities from transactions in over-the-counter markets (Level 2), was $5,263.3 million.